Delivery Order SPE2DB20D3103-SPE2DB24FM7W5
Award Date
2/23/24
Potential Completion Date
3/15/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $3,203.98 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract, valued at $3,141.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 2, 2024. This award is not associated with any set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,673.88 contract is for the delivery of PROQUAD VIALS to a location in Conshohocken, Pennsylvania by March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $3,203.98, is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,601.99, is a firm fixed price delivery order with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROQUAD VIALS to support military treatment programs and facilities. The contract, valued at $7,363.93, has a completion date of May 2, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $9,611.94 and a completion date of January 30, 2024. The award was made on January 8, 2024, and there was no...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,623.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract worth $32,039.80 for PROQUAD VIALS. The contract has a firm fixed price and an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at...